Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Re:NewCell on its IPO
Mandate

Vinge advises Re:NewCell on its IPO

November 27, 2020 Banking and Finance M&A Corporate Tax Capital Markets and Public M&A

Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Market.

The company is the first in the world to commercially offer a dissolving pulp for textile production manufactured from 100 per cent recycled textiles.

The Vinge team includes Christian Lindhé, Erik Sjöman, Ludvig Frithiof and Nora Gullberg (Capital Markets and Public M&A), Henrik Ossborn and Jack Bengtsson (Banking and Finance), Anna Edström and Martin Svanberg (M&A) as well as Maria Schultzberg (Tax).

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025